This paper is in the following e-collection/theme issue:

Prevention and Health Promotion (179) Secondary Use of Clinical Data for Research and Surveillance (103) Infectious Diseases (non-STD/STI) (690) Influenza and Influenza-Like-Illness (ILI) Surveillance (64) Innovative Methods in Public Health and Surveillance (110) Surveillance Systems (212)

Published on in Vol 5, No 4 (2019): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12016, first published .
Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study

Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study

Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study

Authors of this article:

Simon de Lusignan 1 Author Orcid Image ;   Ana Correa 1 Author Orcid Image ;   Gaël Dos Santos 2 Author Orcid Image ;   Nadia Meyer 2 Author Orcid Image ;   François Haguinet 2 Author Orcid Image ;   Rebecca Webb 1 Author Orcid Image ;   Christopher McGee 1, 3 Author Orcid Image ;   Rachel Byford 1 Author Orcid Image ;   Ivelina Yonova 1, 3 Author Orcid Image ;   Sameera Pathirannehelage 1 Author Orcid Image ;   Filipa Matos Ferreira 1 Author Orcid Image ;   Simon Jones 1, 4 Author Orcid Image
Article Authors Cited by (3) Tweetations (4) Metrics

Journals

  1. Dos Santos G. Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives. Human Vaccines & Immunotherapeutics 2019;15(11):2624 View
  2. Dos Santos G, Nguyen B, Damaso S, Godderis L, Martínez-Gómez X, Eckermann T, Loos H, Salamanca de la Cueva I, Shende V, Schmidt A, Yeakey A. Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season. Drug Safety 2020;43(3):265 View
  3. Dos Santos G, Shende V, Damaso S, Yeakey A. Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis. Advances in Therapy 2019;36(12):3340 View